CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Provexis PLC Company Snapshot
Provexis PLC operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Provexis PLC with three other pharmaceutical manufacturers in Europe: Moberg Pharma AB (publ) of SWEDEN (2020 sales of 50.49 million Swedish Kronor [US$6.05 million] ), Oncimmune Holdings PLC (£509,000.00 [US$693,461.60 ] of which 100% was Distribution of testing products), and Medincell SA which is based in FRANCE (2.85 million Euros [US$3.46 million] of which 100% was mers allowing the controlled and prolong).

Sales Analysis. During the year ended March of 2020, sales at Provexis PLC were £347,937.00 (US$474.03 thousand). This is an increase of 8.0% versus 2019, when the company's sales were £322,189.00 . This was the fifth consecutive year of sales increases at Provexis PLC (and since 2015, sales have increased a total of 810%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Provexis PLC
  Stock Performance Chart for Provexis PLC
 
  Stock Data: Recent Stock Performance:
  Current Price (1/15/2021): .83p
(Figures in Pounds Sterling)
1 Week 3.1%   13 Weeks 3.1%  
4 Weeks 43.5%   52 Weeks 22.2%  
 
Provexis PLC Key Data:
  Ticker: PXS Country: United Kingdom
  Exchanges: LON Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2020 Sales 347,937
(Year Ending Jan 2021).
Employees: 4
  Currency: Pounds Sterling Market Cap: 16,989,402
  Fiscal Yr Ends: March Shares Outstanding: 2,059,321,507
  Share Type: Ordinary Closely Held Shares: 409,513,462
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.